StonvexLoading…
StonvexStonvexStonvexCore line items from SCND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.05M | $4.80M | $11.11M | $5.24M |
Operating Income | $-7.89M | $-8.22M | $-9.26M | $-4.14M |
Net Income | $-1.22M | $-6.45M | $-9.09M | $-4.08M |
EPS (Diluted) | $-0.11 | $-0.61 | $-1.27 | $-0.58 |
Total Assets | $12.61M | $11.56M | $16.73M | $18.07M |
Total Liabilities | $1.94M | $2.44M | $2.85M | $3.28M |
Cash & Equivalents | $955.00K | $587.90K | $796.10K | $1.93M |
Free Cash Flow OCF − CapEx | $-8.21M | $-3.78M | $-6.29M | $-3.10M |
Shares Outstanding | 11.93M | 10.50M | 10.15M | 7.00M |